LingVo.club
📖+20 XP
🎧+15 XP
+25 XP
AI tool helps local autism diagnosis in Missouri — Level A2 — text

AI tool helps local autism diagnosis in MissouriCEFR A2

28 Dec 2025

Adapted from Eric Stann-Missouri, Futurity CC BY 4.0

Photo by Annie Spratt, Unsplash

Level A2 – High beginner / Elementary
3 min
134 words

Long waits for autism diagnosis are a big problem in many parts of the United States. In Missouri many families wait nearly a year and must travel far to reach specialty centres. Researchers at the University of Missouri School of Medicine worked with the company Cognoa to test an FDA-approved device called CanvasDx. The device uses AI and patient information to predict a positive or negative autism diagnosis. If the information is not clear, it returns an "indeterminate" result.

The study used the ECHO Autism community to work with primary care clinicians. Keeping care local helped families get a diagnosis several months sooner. In the sample of 80 children the device gave determinate results for about half and did not produce false positives or false negatives, and it never contradicted a clinician's diagnosis.

Difficult words

  • diagnosisa doctor’s identification of an illness or condition
  • specialtya specific area of medical care or work
  • indeterminatenot clear or not decided yet
  • primary carebasic medical care from a local doctor
  • false positivea test result that wrongly shows a disease is present
    false positives
  • predictsay what will likely happen before it does

Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.

Discussion questions

  • How could a faster diagnosis help a family with a child?
  • What do you think about using AI to help medical diagnosis? Why?
  • Would you prefer care close to home or travel to a specialist? Why?

Related articles

Tofersen slows a rare form of ALS — Level A2
26 Dec 2025

Tofersen slows a rare form of ALS

A long-term study shows that tofersen, a drug for a rare genetic form of ALS, can slow disease progression and help some people improve. The trial followed participants for several years and recorded benefits and side effects.